Duopharma quarterly showing rises

Duopharma’s fourth-quarter net profit rose to RM15.08mil from RM8.5mil a year ago.

PETALING JAYA: Duopharma Biotech Bhd aims to deliver a satisfactory performance in 2025, barring unforeseen market changes and developments.

In a filing with Bursa Malaysia, Duopharma said this would be achievable with a resolute focus on sustainable growth, cost optimisation and operational resilience.